JOURNAL DESCRIPTION

The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.

Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.

Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.

The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.

Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.

The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.

Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.

The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.

Medical Radiology and Radiation Safety. 2018. Vol. 63. No. 1. P. 53-56

NUCLEAR MEDICINE

DOI: 10.12737/article_5a85541371b9d7.91570726

The Possibility of Using the Sodium-Fluoride, 18F at Non-Neoplastic Lesions of Bone Tissue (Experimental Study)

N.A. Kostenikov, V.F. Dubrovskaya, O.Yu. Mirolyubova, O.V. Klestova, E.G. Kovan’ko, N.N. Izotova, Yu.R. Ilushchenko, A.A. Stanzhevsky

A.M. Granov Russian Research Center for Radiology and Surgical Technologies, Saint Petersburg, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

N.A. Kostenikov - Head of the Lab., Dr. Sc. Med.; V.F. Dubrovskaya - Leading Researcher, Dr. Sc. Med.; O.Y. Mirolyubova - Senior Researcher, PhD Med.; O.V. Klestova - Senior Researcher, PhD Med.; E.G. Kovan’ko - Senior Researcher, PhD Med.; N.N. Izotova - Technician; Y.R. Ilyushchenko - Researcher; A.A. Stanzhevsky - Deputy Director Dr. Sc. Med.

Abstract

Purpose: To study the possibility of using radiopharmaceutical (RPH) Sodium fluoride, 18F (Na18F) in order to identify the characteristics and dynamics of the development process for a number of non-neoplastic lesions in bone tissue such as fractures and osteoporosis in experimental animals by the method of positron emission tomography (PET).

Material and methods: Two experimental models of pathology of bone tissue in rats were used: fracture and osteoporosis.

The model of osteoporosis was created by intraperitoneal introduction of hydrocortisone during 3 weeks. The study was conducted in 22 days from the onset of the agent introduction. In areas of the chest and sacral sections of the spinal cord in experimental and intact animals we detected the value of uptake of Na18F, as well as indices of tissue density with data of X-ray CT.

In the model of fracture of bones injury struck in the pre-anesthetized rats in the region of the shin. Animals were examined starting from the 3rd day up to the 30th day after the fracture by PET and PET/CT. We detected the value of uptake, the dynamics of Na18F accumulation, as well as indices of densitometry and signs of callus formation with CT examination.

Results: In rats with osteoporosis compared with intact animals observed a 2,5-fold decrease of the bone tissue density in X-ray, whereas the level of metabolic activity in the bones of the PET scan with Na18F was 5.6 times lower than in healthy rats. Therefore, differences in the level of capture of the radiopharmaceutical in PET were significantly more important compared to the ratio of the values of the X-ray of the bone tissue density, determined by CT.

In experiments with shin fracture was noted hyperfixation and increasing rate of Na18F accumulation on PET-scans since the 9th and 30th day from the start of the experiment. It reflects a process of enhancing the metabolism in the injured area. At the same time, a significant increase of densitometric density and visualisation of callus formation in the fracture by CT were detected 3 weeks later, - only by the 30th day after trauma.

Conclusion: The use of Na18F in positron-emission tomography enables to diagnose more early and accurate the nature (osteoporosis) and intensity of processes of the restoration (fracture) in the injured bone tissue as compared to results of computed tomography.

Key words: radiopharmaceutical, positron emission tomography, osteoporosis, bone fracture, animals

REFERENCES

  1. Blau M, Nagler W, Bender MA. Fluorine-18: a new isotope for bone scanning. J. Nucl. Med. 1962;3:332-4.
  2. Blau M, Ganatra R, Bender MA. 18F-fluoride for bone imaging. Semin. Nucl. Med. 1972;2:31-7. DOI: 10.1016/S0001-2998(72)80005-9.
  3. Langsteger W, Heinisch M, Fogelman I. The role of fluorode­oxy­glucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Nucl. Med. 2006;36:73-92. DOI: 10.1053/j.semnuclmed.2005.09.002.
  4. Weber DA, Greenberg EJ, Dimich A, et al. Kinetics of radio­nuclides used for bone studies. J. Nucl. Med. 1969;10:8-17.
  5. Wootton R, Dore C. The single-passage extraction of 18F in rabbit bone. Clin. Phys. Physiol. Meas. 1986;7:333-43.
  6. Carlson CH, Armstrong WD, Singer L. Distribution, migra­tion and binding of whole blood fluoride evaluated with radiofluo­ride. J. Physiol. 1960;199:187-9. DOI: 10.1152/ajplegacy.1960.199.1.187.
  7. Costeas A, Woodard HQ, Laughlin JS. Depletion of 18F from blood flowing through bone. J. Nucl. Med. 1970;11:43-5.
  8. Hawkins RA, Choi Y, Huang S.C., et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. Nucl. Med. 1992;33:633-42.
  9. [Guidelines for working with laboratory animals for the staff of the N.I. Pirogov Russian National Research Medical University engaged in conducting preclinical trials]. Moscow; 2015. 42 p. Russian.
  10. [The Russian State Standard (GOST) R 53434-2009 “Principles of good laboratory practice”]. Moscow; 2010. 28 p. Russian.
  11. [The order No. 119n dated 2016 Apr 1 of the Ministry of Health and Social Development of the Russian Federation “On approval of rules of good laboratory practice”. Ministry of Health of the Russian Federation]; 2016. Russian.
  12. Hellwig D, Krause B-J, Schirrmeister H, Freesmeyer M. Skelettdiagnostik Mittels 18F-Natriumfluorid-PET und PET/CT. Nuklearmedizin. 2010;5:195-201. DOI: 10.3413/Nukmed-0311-10-04.

For citation: Kostenikov NA, Dubrovskaya VF, Mirolyubova OYu, Klestova OV, Kovan’ko EG, Izotova NN, Ilushchenko YuR, Stanzhevsky AA. The Possibility of Using the Sodium-Fluoride, 18F at Non-Neoplastic Lesions of Bone Tissue (Experimental Study). Medical Radiology and Radiation Safety. 2018;63(1):53-6. DOI: 10.12737/article_5a85541371b9d7.91570726. Russian.

PDF (RUS) Full-text article (in Russian)

Contact Information

 

46, Zhivopisnaya st., 123098, Moscow, Russia Phone: +7 (499) 190-95-51. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal location

Attendance

2765556
Today
Yesterday
This week
Last week
This month
Last month
For all time
1450
4471
23940
18409
73299
75709
2765556

Forecast today
3264


Your IP:216.73.216.159